IQVIA Holdings Inc. (NYSE:IQV) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of IQVIA Holdings Inc. (NYSE:IQV) have been given an average rating of “Moderate Buy” by the twenty-one ratings firms that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $255.71.

IQV has been the subject of several analyst reports. Truist Financial dropped their target price on shares of IQVIA from $265.00 to $261.00 and set a “buy” rating for the company in a research report on Thursday, December 12th. William Blair restated an “outperform” rating on shares of IQVIA in a report on Wednesday, December 11th. Evercore ISI reduced their target price on shares of IQVIA from $270.00 to $265.00 and set an “outperform” rating for the company in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their target price on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating for the company in a research note on Friday, November 1st. Finally, BTIG Research reduced their price target on shares of IQVIA from $290.00 to $260.00 and set a “buy” rating for the company in a research report on Friday, November 1st.

IQVIA Stock Performance

Shares of IQV opened at $204.54 on Friday. The firm has a 50-day moving average of $199.71 and a 200-day moving average of $221.06. The company has a debt-to-equity ratio of 1.76, a current ratio of 0.81 and a quick ratio of 0.81. The company has a market cap of $37.12 billion, a PE ratio of 26.84, a price-to-earnings-growth ratio of 2.14 and a beta of 1.48. IQVIA has a one year low of $187.62 and a one year high of $261.73.

Institutional Investors Weigh In On IQVIA

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Capital Performance Advisors LLP purchased a new position in shares of IQVIA during the third quarter worth approximately $27,000. Park Place Capital Corp bought a new stake in IQVIA in the third quarter valued at $28,000. Avior Wealth Management LLC boosted its holdings in IQVIA by 117.6% in the third quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company’s stock valued at $38,000 after acquiring an additional 87 shares in the last quarter. Synergy Asset Management LLC purchased a new position in IQVIA during the fourth quarter valued at $33,000. Finally, Assetmark Inc. raised its position in shares of IQVIA by 612.5% in the 3rd quarter. Assetmark Inc. now owns 228 shares of the medical research company’s stock worth $54,000 after purchasing an additional 196 shares during the last quarter. 89.62% of the stock is owned by hedge funds and other institutional investors.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.